Publication | Open Access
Everolimus precision therapy for the <scp>GATOR1</scp>‐related epilepsies: A case series
26
Citations
14
References
2023
Year
Our study provides the first human data on the potential benefit of everolimus precision therapy for epilepsy caused by DEPDC5 loss-of-function variants. Further studies are needed to support our findings.
| Year | Citations | |
|---|---|---|
Page 1
Page 1